CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 100 target
Drug / intervention
pancreaticoduodenectomy procedureprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07022015
NCT07022015N/ARecruitingOn TrackUpdated 12mo ago

Predictive Risk Factors for Postoperative Pancreatic Fistula After Pancreaticoduodenectomy for Malignancy.

Minia University·interventional·Posted Jun 15, 2025·Updated Jun 22, 2025

In Brief

A clinical study evaluating pancreaticoduodenectomy procedure for Pancreas Cancer and 6 related conditions. Currently recruiting, targeting 100 participants across 1 site.

Detailed Summary

Pancreaticoduodenectomy (PD) is a complex procedure performed in patients with malignant or benign tumors of the pancreatic head and periampullary region, associated with high morbidity and mortality. Postoperative pancreatic fistula (POPF) is the most common and clinically significant complication following PD. In this study, the investigators aim to determine the predictive risk factors for clinically related postoperative pancreatic fistula (CR-POPF) in the preoperative, intraoperative and postoperative period in patients that underwent PD. The total number of 100 participants expected to be included in this research who underwent PD between 2025 and 2026.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesEgypt
Collaborators--

Timeline

N/ARecruiting
2026
First PostedJun 15, 2025
Enrollment StartJun 20, 2025
Primary CompletionJun 20, 2026
Study CompletionJul 20, 2026
TodayJul 1, 2026
Enrollment to primary: 1 yearPosted 1.0 years ago

Interventions

pancreaticoduodenectomy procedureprocedure

Pancreaticoduodenectomy operation